...
首页> 外文期刊>FEBS Letters >Phenylalanine ammonia‐lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria
【24h】

Phenylalanine ammonia‐lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria

机译:苯丙氨酸解氨酶固定在半透性微胶囊中,用于苯丙酮尿症的酶替代

获取原文
           

摘要

>Phenylalanine ammonia-lyase immobilized within semipermeable microcapsules has an assayed enzyme activity which is 20% ± 4% of the enzyme in free solution. The Km for the immobilized enzyme remained the same as that of the free enzyme. The pH optimum also remained unchanged at pH 8.5 ± 1.0. At the lower pH range, enzyme activity is higher for the immobilized enzyme. Daily oral administration of microencapsulated phenylalanine ammonia-lyase to phenylketonuric rats decreased the systemic phenylalanine level by 35 ± 8% in 2 days (P 0.05) and by 75 ± 8% in 7 days (P 0.001).
机译:固定在半透性微胶囊中的苯丙氨酸氨裂合酶具有测定的酶活性,该酶活性为游离溶液中酶的20%±4%。固定化酶的 K m 与游离酶相同。最适pH在pH 8.5±1.0时也保持不变。在较低的pH范围内,固定化酶的酶活性较高。每天对苯丙酮尿症大鼠口服微囊化苯丙氨酸氨裂合酶可使全身苯丙氨酸水平在2天内降低35±8%( P <0.05),在7天内降低75±8%( P <0.001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号